Disclosure: This is an affiliate site. We may earn compensation from partners. Full disclosure | Medical disclaimer
One price at any dose, no membership, no auto-billing
$232/mo
Compounded
Cash-pay
August 30, 2026
SkinnyVIP sells compounded tirzepatide at one price regardless of dose: $695 for a three-month plan, working out to about $232 a month, or $350 for a single month. Compounded semaglutide is also available.
The flat-dose model is the point. Most competitors advertise a low entry rate that applies only to the starting dose and climbs steeply as you titrate — SkinnyVIP charges the same from your starting dose through maintenance.
It also explicitly rejects the subscription model: no memberships, no contracts, no auto-billing. The company positions itself directly at people leaving larger platforms, with a landing page aimed at "Hims & Ro refugees."
SkinnyVIP dispenses compounded tirzepatide and semaglutide. Compounded drugs are not FDA-approved and the FDA does not evaluate them for safety, effectiveness or quality.
Online intake reviewed by a licensed provider, included in the plan price.
Adults meeting standard GLP-1 criteria as assessed by the reviewing provider.
Licensed providers handle prescribing and dose adjustments, included in the price.
Not publicly listed as a standard requirement.
Compounding pharmacies. Specific partners are not publicly named.
Included in the plan price. Injectable compounded GLP-1s require refrigerated handling.
Provider access included. No retention calls, since there is no subscription to cancel.
None. SkinnyVIP states it does not require memberships, contracts or auto-billing.
Included in the plan price, which does not change with dose.
Nothing recurring to cancel — you buy a plan rather than subscribing. Three-month plans are paid upfront.
Not publicly confirmed in the material we reviewed. Compounded medication cannot be returned once dispensed.
Not accepted. Compounded GLP-1s are not insurance-eligible.
Reimbursement for compounded medication is uncertain. Confirm with your plan administrator.
Pricing in this review reflects what SkinnyVIP and named third-party sources published as of August 30, 2026. Telehealth pricing changes frequently — confirm the current figure at checkout before you buy.
People who expect to titrate to a high maintenance dose and want the price to stay put, and anyone who specifically wants to avoid auto-billing.
Flat pricing only pays off if you titrate high enough that dose-tiered competitors overtake $232. At a starting dose you can pay considerably less elsewhere. Run the numbers for your expected maintenance dose first.
Compounded tirzepatide is $695 for a three-month plan — about $232 a month — or $350 for a single month. The price is the same at any dose, and there is no membership fee.
No. SkinnyVIP charges the same from your starting dose through maintenance. That is the main reason to consider it over providers whose advertised rate applies only to the lowest dose.
No. The company states it does not require memberships, contracts or auto-billing. You buy a one-month or three-month plan outright.
No. SkinnyVIP dispenses compounded tirzepatide and semaglutide, which are not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness or quality.
It markets itself that way, with a landing page aimed at people leaving those platforms. Whether it is cheaper for you depends on your dose — flat pricing at $232 beats dose-tiered competitors at high doses and loses to them at starting doses.
Every pricing and policy claim on this page traces back to one of these sources, checked on August 30, 2026.
About $232/month, any dose, all-inclusive
Any dose, no commitment
No memberships, contracts or auto-billing
Verified August 30, 2026. Prices change often — confirm before purchase.
Share your experience with SkinnyVIP to help others make informed decisions.
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with serious potential side effects and are not appropriate for everyone. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Compounded medications are not FDA-approved. The FDA does not evaluate compounded products for safety, effectiveness, or quality. Individual results vary. This page contains affiliate links, and we may earn compensation if you use them.
Date reviewed: August 30, 2026